Beth LeBow
Lawyers
Filters
Tenaya Therapeutics $75 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
RxSight $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Cryoport $403 million notes offering and concurrent $249 million stock offering
The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering
Aligos Therapeutics $75 million at-the-market offering
The company issued common stock in the SEC-registered at-the-market offering
ForgeRock $316 million IPO
We advised the underwriters on the IPO and NYSE listing
Ingram Micro $7.2 billion acquisition by Platinum Equity
We advised Ingram Micro on the transaction
Aligos Therapeutics $83.6 million follow-on offering
We advised the underwriters on the stock offering
Marvell Technology private exchange offers
We advised the dealer manager in connection with the private exchange offers
Marvell Technology $2 billion senior notes offering
We advised the initial purchasers on the unregistered debt offering
VIZIO Holding $257.2 million IPO
We advised the underwriters on the IPO and NYSE listing